N-(Decanoyl)Pyrrolidine

N-(Decanoyl)Pyrrolidine

SCHEMBL692598

CCCCCCCCCC(=O)N1CCCC1

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.96
MEN1 O00255 2/20 0.92
KMT2A Q03164 2/20 0.92
TDP1 Q9NUW8 1/20 0.92
ATM Q13315 1/20 0.68
GNAI3 P08754 9/20 0.68
GNAI1 P63096 9/20 0.68
GNAO1 P09471 8/20 0.64
POLB P06746 1/20 0.54
MAPT P10636 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27508518 1.00 L3MBTL1 (0.96) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL10494122 1.00 L3MBTL1 (0.96) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL28152342 1.00 L3MBTL1 (0.96) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL10534175 1.00 L3MBTL1 (0.96) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL249052 1.00 L3MBTL1 (0.96) L3MBTL1MEN1KMT2ATDP1ATM
N-(Decanoyl)Pyrrolidine SCHEMBL10755236 1.00 L3MBTL1 (0.96) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL151361 1.00 L3MBTL1 (0.96) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL10534171 1.00 L3MBTL1 (0.96) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL10290341 1.00 L3MBTL1 (0.96) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL28149836 1.00 L3MBTL1 (0.96) L3MBTL1MEN1KMT2ATDP1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114034787-B Method for measuring sensory related amide compounds in main stream smoke of cigarettes 中国烟草总公司郑州烟草研究院 2024-05-03 CN claimed
CN-114034790-B Method for determining sensory related amide compounds in tobacco and tobacco products 中国烟草总公司郑州烟草研究院 2024-03-08 CN claimed
EP-2710892-B1 Use of sarmentine and its analogs for controlling weeds MARRONE BIO INNOVATIONS INC (US) 2016-12-14 EP claimed
US-8957000-B2 Use of sarmentine and its analogs for controlling plant pests MARRONE BIO INNOVATIONS, INC. (US) 2015-02-17 US claimed
US-20150030577-A1 CONTROL OF PHYTOPATHOGENIC MICROORGANISMS WITH PSEUDOMONAS SP. AND SUBSTANCES AND COMPOSITIONS DERIVED THEREFROM MARRONE BIO INNOVATIONS, INC. (US) 2015-01-29 US claimed
EP-2820140-A1 CONTROL OF PHYTOPATHOGENIC MICROORGANISMS WITH PSEUDOMONAS SP. AND SUBSTANCES AND COMPOSITIONS DERIVED THEREFROM Marrone Bio Innovations, Inc. (US) 2015-01-07 EP claimed
CN-104254611-A Control of phytopathogenic microorganisms with pseudomonas sp. and substances and compositions derived therefrom MARRONE BIO INNOVATIONS INC 2014-12-31 CN claimed
EP-2710892-A2 Use of sarmentine and its analogs for controlling plant pests Marrone Bio Innovations, Inc. (US) 2014-03-26 EP claimed
US-20130281294-A1 USE OF SARMENTINE AND ITS ANALOGS FOR CONTROLLING PLANT PESTS PRO FARM GROUP, INC. 2013-10-24 US claimed
WO-2013130680-A1 CONTROL OF PHYTOPATHOGENIC MICROORGANISMS WITH PSEUDOMONAS SP. AND SUBSTANCES AND COMPOSITIONS DERIVED THEREFROM MARRONE BIO INNOVATIONS, INC. (US) 2013-09-06 WO claimed
US-20130121978-A1 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS MARRONE BIO INNOVATIONS, INC. (US) 2013-05-16 US claimed
EP-2456305-A2 USE OF SARMENTINE AND ITS ANALOGS FOR CONTROLLING PLANT PESTS Marrone Bio Innovations, Inc. (US) 2012-05-30 EP claimed
WO-2012065038-A2 AGENTS FOR THE CONTROL OF LIMNOPERNA SP. MARRONE BIO INNOVATIONS, INC. (US) 2012-05-18 WO claimed
US-20120121745-A1 AGENTS FOR THE CONTROL OF LIMNOPERNA SP. MARRONE BIO INNOVATIONS, INC. (US) 2012-05-17 US claimed
CN-102404993-A Chemical and biological agents for the control of molluscs MARRONE BIO INNOVATIONS INC 2012-04-04 CN claimed
EP-2421375-A2 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS Marrone Bio Innovations, Inc. (US) 2012-02-29 EP claimed
WO-2011011415-A2 USE OF SARMENTINE AND ITS ANALOGS FOR CONTROLLING PLANT PESTS MARRONE BIO INNOVATIONS, INC. (US) 2011-01-27 WO claimed
US-20110021358-A1 USE OF SARMENTINE AND ITS ANALOGS FOR CONTROLLING PLANT PESTS MARRONE BIO INNOVATIONS, INC. (US) 2011-01-27 US claimed
WO-2010123894-A2 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS MARRONE BIO INNOVATIONS, INC. (US) 2010-10-28 WO claimed
US-20100266717-A1 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS MARRONE BIO INNOVATIONS, INC. (US) 2010-10-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100266717-A1 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS ACHE, POLI, POLL L3MBTL1 3299/4885MEN1 3759/4885KMT2A 1501/4885
US-20130281294-A1 USE OF SARMENTINE AND ITS ANALOGS FOR CONTROLLING PLANT PESTS SARM1, SMOX, STOM L3MBTL1 229/4885MEN1 3542/4885KMT2A 1428/4885
US-20150030577-A1 CONTROL OF PHYTOPATHOGENIC MICROORGANISMS WITH PSEUDOMONAS SP. AND SUBSTANCES AND COMPOSITIONS DERIVED THEREFROM PGM2, Q6ZSR9, PMM2 L3MBTL1 4046/4885MEN1 4785/4885KMT2A 3805/4885
US-20110021358-A1 USE OF SARMENTINE AND ITS ANALOGS FOR CONTROLLING PLANT PESTS SARM1, SMOX, STOM L3MBTL1 229/4885MEN1 3542/4885KMT2A 1428/4885
US-20120121745-A1 AGENTS FOR THE CONTROL OF LIMNOPERNA SP. LIMK1, LIMA1, LIMK2 L3MBTL1 960/4885MEN1 3831/4885KMT2A 1746/4885
US-20130121978-A1 CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS ACHE, POLI, POLL L3MBTL1 3299/4885MEN1 3759/4885KMT2A 1501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.